The WHO said on Thursday the drugs and other candidate vaccines should be evaluated in clinical trials to generate data on their use. The agency and outside experts have been working to identify several candidates. The move comes as an outbreak continues in the Democratic Republic of the Congo, with cases also reported in Uganda.
There are currently no approved vaccines or therapies specifically for the Bundibugyo virus disease, the WHO said. Among vaccines, a single-dose candidate known as rVSV Bundibugyo, being developed by the International AIDS Vaccine Initiative, was seen as the most promising.
